Edition:
United States

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

86.87USD
4:01pm EDT
Change (% chg)

$-1.24 (-1.41%)
Prev Close
$88.11
Open
$88.15
Day's High
$88.62
Day's Low
$86.81
Volume
748,971
Avg. Vol
785,015
52-wk High
$88.62
52-wk Low
$75.71

Chart for

About

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins,... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $61,209.13
Shares Outstanding(Mil.): 694.69
Dividend: 0.14
Yield (%): 0.64

Financials

  Industry Sector
P/E (TTM): -- 162.11 16.18
EPS (TTM): -- -- --
ROI: -- 9.48 14.60
ROE: -- 14.67 13.87

Hearing-aid maker Sonova names Danaher's Kaldowski as new CEO

ZURICH, Sept 1 Sonova on Friday named Arnd Kaldowski as new chief executive officer as the Swiss company renews leadership following acquisitions and product introductions aimed at protecting its perch as the world's largest hearing aid maker.

Sep 01 2017

BRIEF-Danaher reports Q2 earnings per share $0.79

* Sees Q3 2017 adjusted non-gaap earnings per share $0.92 to $0.96

Jul 20 2017

BRIEF-Danaher announces pricing of euro-denominated senior notes offering

* Danaher announces pricing of euro-denominated senior notes offering

Jun 20 2017

BRIEF-Danaher Q1 earnings per share $0.69

* Sees Q2 2017 adjusted non-GAAP earnings per share $0.95 to $0.98

Apr 20 2017

BRIEF-Danaher CEO's total compensation was about $13 million

* CEO Thomas Joyce's 2016 total compensation was about $13 million versus $10.6 million in 2015

Mar 31 2017

Earnings vs. Estimates